VectivBio Holding AG (VECT) Stock Price, Quote, News and Overview
NASDAQ:VECT - Nasdaq - CH1109007893 - Common Stock - Currency: USD
VECT Quote, Performance and Key Statistics
NASDAQ:VECT (7/7/2023, 8:07:59 PM)
16.85
0 (0%)
The current stock price of VECT is 16.85 USD. In the past month the price increased by 1.08%. In the past year, price increased by 186.54%.
VECT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 20.17 | 360.64B | ||
| AMGN | AMGEN INC | 15.63 | 166.32B | ||
| GILD | GILEAD SCIENCES INC | 24.08 | 138.34B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1660.86 | 123.74B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.63 | 77.97B | ||
| ARGX | ARGENX SE - ADR | N/A | 38.04B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.11B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.04B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.58B | ||
| NTRA | NATERA INC | N/A | 20.91B | ||
| BIIB | BIOGEN INC | 8.58 | 20.59B | ||
| UTHR | UNITED THERAPEUTICS CORP | 15.73 | 15.99B |
Related stock screener links
About VECT
Company Profile
VectivBio Holding AG is a clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of treatments for severe rare conditions with significant unmet medical need. The company is headquartered in Basel, Basel-Stadt and currently employs 42 full-time employees. The company went IPO on 2021-04-09. The firm trough it's subsidiaries operates as a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of treatments for severe rare conditions for which there is a significant unmet medical need.
Company Info
VectivBio Holding AG
Aeschenvorstadt 36
Basel BASEL-STADT 22046 CH
Employees: 42
Phone: 41615513030.0
VectivBio Holding AG / VECT FAQ
What is the stock price of VectivBio Holding AG today?
The current stock price of VECT is 16.85 USD.
What is the ticker symbol for VectivBio Holding AG stock?
The exchange symbol of VectivBio Holding AG is VECT and it is listed on the Nasdaq exchange.
On which exchange is VECT stock listed?
VECT stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for VectivBio Holding AG stock?
8 analysts have analysed VECT and the average price target is 18.36 USD. This implies a price increase of 8.96% is expected in the next year compared to the current price of 16.85. Check the VectivBio Holding AG stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is VectivBio Holding AG worth?
VectivBio Holding AG (VECT) has a market capitalization of 1.06B USD. This makes VECT a Small Cap stock.
How many employees does VectivBio Holding AG have?
VectivBio Holding AG (VECT) currently has 42 employees.
What are the support and resistance levels for VectivBio Holding AG (VECT) stock?
VectivBio Holding AG (VECT) has a support level at 16.84 and a resistance level at 16.89. Check the full technical report for a detailed analysis of VECT support and resistance levels.
Is VectivBio Holding AG (VECT) expected to grow?
The Revenue of VectivBio Holding AG (VECT) is expected to decline by -96.99% in the next year. Check the estimates tab for more information on the VECT EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy VectivBio Holding AG (VECT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of VECT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of VECT, evaluating the profitability, health, valuation and growth aspects
- VectivBio Holding AG (VECT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- VectivBio Holding AG (VECT) Sales and EPS estimates to see what analysts future expectations are.
- VectivBio Holding AG (VECT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- VectivBio Holding AG (VECT) Insider and Institutional Ownership to learn about the owners and their transactions.
- VectivBio Holding AG (VECT) Stock Chart to make your own analysis
- VectivBio Holding AG (VECT) Latest news and press-releases to stay up to date.
Does VectivBio Holding AG (VECT) stock pay dividends?
VECT does not pay a dividend.
What is the Price/Earnings (PE) ratio of VectivBio Holding AG (VECT)?
VectivBio Holding AG (VECT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.87).
VECT Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to VECT. When comparing the yearly performance of all stocks, VECT is one of the better performing stocks in the market, outperforming 98.97% of all stocks.
VECT Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to VECT. The financial health of VECT is average, but there are quite some concerns on its profitability.
VECT Financial Highlights
Over the last trailing twelve months VECT reported a non-GAAP Earnings per Share(EPS) of -1.87. The EPS increased by 22% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0.05 |
VECT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 48% to VECT. The Buy consensus is the average rating of analysts ratings from 8 analysts.
For the next year, analysts expect an EPS growth of 8.67% and a revenue growth -96.99% for VECT